H.C. Wainwright Maintained Seres Therapeutics (MCRB) As Buy; Has Price Target Of $19.0000; Zimmer Partners LP Has Boosted By $15.75 Million Its American Tower New (AMT) Position

August 4, 2017 - By Clifton Ray

Zimmer Partners Lp increased American Tower Corp New (AMT) stake by 85.71% reported in 2016Q4 SEC filing. Zimmer Partners Lp acquired 150,000 shares as American Tower Corp New (AMT)’s stock rose 18.69%. The Zimmer Partners Lp holds 325,000 shares with $34.35M value, up from 175,000 last quarter. American Tower Corp New now has $59.05B valuation. The stock decreased 0.59% or $0.82 during the last trading session, reaching $137.15. About shares traded. American Tower Corp (NYSE:AMT) has risen 23.66% since August 4, 2016 and is uptrending. It has outperformed by 6.96% the S&P500.

Among 7 analysts covering Seres Therapeutics Inc (NASDAQ:MCRB), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Seres Therapeutics Inc has $60 highest and $16 lowest target. $35.57’s average target is 175.52% above currents $12.91 stock price. Seres Therapeutics Inc had 15 analyst reports since July 21, 2015 according to SRatingsIntel. H.C. Wainwright initiated it with “Buy” rating and $50 target in Friday, July 29 report. The rating was initiated by H.C. Wainwright with “Buy” on Monday, January 25. The stock of Seres Therapeutics Inc (NASDAQ:MCRB) has “Outperform” rating given on Wednesday, March 30 by FBR Capital. The company was initiated on Monday, June 6 by Cowen & Co. The stock of Seres Therapeutics Inc (NASDAQ:MCRB) earned “Outperform” rating by Leerink Swann on Tuesday, July 21. FBR Capital maintained it with “Outperform” rating and $23 target in Friday, August 12 report. Canaccord Genuity maintained Seres Therapeutics Inc (NASDAQ:MCRB) rating on Tuesday, August 25. Canaccord Genuity has “Buy” rating and $50 target. On Tuesday, July 21 the stock rating was initiated by Goldman Sachs with “Neutral”. Canaccord Genuity initiated the stock with “Buy” rating in Wednesday, July 22 report. The firm earned “Neutral” rating on Tuesday, July 21 by Bank of America.

Analysts await Seres Therapeutics Inc (NASDAQ:MCRB) to report earnings on August, 10. They expect $-0.59 EPS, up 15.71% or $0.11 from last year’s $-0.7 per share. After $-0.63 actual EPS reported by Seres Therapeutics Inc for the previous quarter, Wall Street now forecasts -6.35% EPS growth.

The stock decreased 3.08% or $0.41 during the last trading session, reaching $12.91. About shares traded. Seres Therapeutics Inc (NASDAQ:MCRB) has declined 64.58% since August 4, 2016 and is downtrending. It has underperformed by 81.28% the S&P500.

Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The company has market cap of $521.44 million. The Firm is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. It currently has negative earnings. The Company’s drugs are designed to restore health by repairing the function of a dysbiotic microbiome.

Since February 7, 2017, it had 0 insider purchases, and 11 sales for $37.26 million activity. The insider Lara Gustavo sold 20,507 shares worth $2.38M. $5.13M worth of stock was sold by Meyer Robert Joseph JR on Friday, April 28. Another trade for 7,400 shares valued at $938,838 was sold by REED JOANN A. TAICLET JAMES D JR had sold 40,000 shares worth $4.13 million on Tuesday, February 7. SHARBUTT DAVID E sold 3,653 shares worth $469,812. $1.79 million worth of stock was sold by DiSanto Edmund on Thursday, March 23. Shares for $10.95M were sold by HESS WILLIAM H.

Among 16 analysts covering American Tower Corporation (NYSE:AMT), 15 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. American Tower Corporation had 41 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Monday, November 9 by Macquarie Research. The company was maintained on Wednesday, August 10 by Citigroup. On Wednesday, October 7 the stock rating was maintained by JP Morgan with “Overweight”. The stock of American Tower Corp (NYSE:AMT) has “Buy” rating given on Thursday, June 16 by Citigroup. The stock has “Buy” rating by Jefferies on Friday, July 29. Cowen & Co maintained American Tower Corp (NYSE:AMT) on Friday, July 28 with “Buy” rating. The stock has “Buy” rating by Citigroup on Monday, July 11. The company was downgraded on Monday, August 24 by Zacks. The stock of American Tower Corp (NYSE:AMT) has “Buy” rating given on Wednesday, August 17 by Argus Research. The firm has “Outperform” rating given on Friday, April 28 by RBC Capital Markets.

Investors sentiment increased to 1.09 in 2016 Q4. Its up 0.10, from 0.99 in 2016Q3. It increased, as 58 investors sold AMT shares while 271 reduced holdings. 101 funds opened positions while 258 raised stakes. 385.64 million shares or 1.20% less from 390.31 million shares in 2016Q3 were reported. Citizens Northern has 13,027 shares. Dubuque Retail Bank & Tru Company, Iowa-based fund reported 163 shares. M&T Bankshares holds 0.21% or 316,641 shares. Pitcairn Com accumulated 3,893 shares. State Of Tennessee Treasury Department holds 0.16% of its portfolio in American Tower Corp (NYSE:AMT) for 282,576 shares. Selkirk Management Ltd Llc owns 49,150 shares for 3.3% of their portfolio. Bbva Compass Bankshares reported 18,220 shares stake. Resolution, Australia-based fund reported 272,415 shares. Pr Herzig And reported 0.96% stake. 5.85M are held by Deutsche Bankshares Ag. Aperio Grp invested 0.15% in American Tower Corp (NYSE:AMT). Employees Retirement Sys Of Texas invested in 0.36% or 247,400 shares. Wetherby Asset Mngmt stated it has 0.14% of its portfolio in American Tower Corp (NYSE:AMT). Akre Mgmt Lc owns 12.99% invested in American Tower Corp (NYSE:AMT) for 6.70 million shares. Campbell Newman Asset Mgmt stated it has 72,531 shares.

Zimmer Partners Lp decreased Digitalglobe Inc (NYSE:DGI) stake by 359,900 shares to 140,100 valued at $4.01 million in 2016Q4. It also reduced Anadarko Pete Corp (NYSE:APC) stake by 367,708 shares and now owns 3.13 million shares. Cheniere Energy Inc (NYSEMKT:LNG) was reduced too.